DFCM
HRTX icon

Dark Forest Capital Management’s Heron Therapeutics HRTX Stock Holding History

Dark Forest Capital Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,011
Closed -$5.03K – 1302
2022
Q4 		$5.03K Buy
+2,011
New +$6.48K ﹤0.01% 863
2022
Q2 		– Sell
-744
Closed -$4K – 1092
2022
Q1 		$4K Buy
744
+383
+106% +$2.8K ﹤0.01% 1124
2021
Q4 		$3K Sell
361
-2,729
-88% -$27.9K ﹤0.01% 1263
2021
Q3 		$33K Buy
3,090
+2,998
+3,259% +$36.5K 0.01% 675
2021
Q2 		$1K Buy
+92
New +$1.46K ﹤0.01% 779

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dark Forest Capital Management's HRTX Position: Q1 2023 in Review

Dark Forest Capital Management sold out of Heron Therapeutics (HRTX) in Q1 2023, closing a stake of 2,011 shares — an estimated $5.03K sold.

Dark Forest Capital Management first reported a position in HRTX in Q2 2021 and held it in 5 quarters. The position peaked at $33K in Q3 2021. 162 funds tracked by Wall St. Rank hold HRTX as of Q1 2023.

  • Dark Forest Capital Management reported no remaining Heron Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Dark Forest Capital Management sold 2,011 Heron Therapeutics shares in Q1 2023, an estimated $5.03K.
  • Dark Forest Capital Management first reported a position in Heron Therapeutics in Q2 2021 and held it in 5 quarters.
  • Dark Forest Capital Management's Heron Therapeutics position peaked at $33K in Q3 2021.
  • 162 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2023.

Based on Dark Forest Capital Management's 13F filing for Q1 2023, filed 12 May 2023.